// App-Quantinova.ai

16714 : Real-World Cost of All-Cause Hospitalizations Over a 12-Month Period After Acute Venous Thromboembolism

Researchers

Presenter

  • Stephen Johnston

Principal Investigators

  • Yonghua Jing

  • Robyn A Schaiff

  • Jeffrey Trocio

  • Erin Thomson

  • Paul Juneau

  • John Graham

Medical Centers

  • Washington Hospital Ctr., Washington, DC

Locations

  • United States

Companies

  • Pfizer Inc.

  • Bristol-Myers Squibb

  • Truven Health Analyt

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Enoxaparin

  • Enoxaparin sodium

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved